Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
CNO Financial reports Q3 operating EPS 72c, consensus 61c » 16:53
10/27/21
10/27
16:53
10/27/21
16:53
CNO

CNO Financial

$25.78 /

-0.545 (-2.07%)

Reports Q3 revenue…

Reports Q3 revenue $968.3M, consensus $1.01B a year ago. "CNO reported another successful quarter," said CEO Gary Bhojwani. "We continue to benefit from the outstanding work and customer commitment of our associates and agents. Our results reflect the consistent execution of our strategy, particularly within our direct-to-consumer business. Earnings continued to benefit from deferral of care within our health lines and very strong alternative investment performance. We approach the end of the year on solid footing and remain well-positioned to serve our clients and communities, and generate value for our shareholders."

ShowHide Related Items >><<
CNO CNO Financial
$25.78 /

-0.545 (-2.07%)

CNO CNO Financial
$25.78 /

-0.545 (-2.07%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
CNO CNO Financial
$25.78 /

-0.545 (-2.07%)

Conference/Events
CNO Financial management to meet virtually with Piper Sandler » 04:55
09/22/21
09/22
04:55
09/22/21
04:55
CNO

CNO Financial

$22.18 /

-0.22 (-0.98%)

Virtual Meetings to be…

Virtual Meetings to be held on September 21-22 hosted by Piper Sandler.

ShowHide Related Items >><<
CNO CNO Financial
$22.18 /

-0.22 (-0.98%)

CNO CNO Financial
$22.18 /

-0.22 (-0.98%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
CNO CNO Financial
$22.18 /

-0.22 (-0.98%)

Conference/Events
CNO Financial management to meet virtually with Piper Sandler » 04:55
09/21/21
09/21
04:55
09/21/21
04:55
CNO

CNO Financial

$22.40 /

-0.945 (-4.05%)

Virtual Meetings to be…

Virtual Meetings to be held on September 21-22 hosted by Piper Sandler.

ShowHide Related Items >><<
CNO CNO Financial
$22.40 /

-0.945 (-4.05%)

CNO CNO Financial
$22.40 /

-0.945 (-4.05%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
CNO CNO Financial
$22.40 /

-0.945 (-4.05%)

Conference/Events
CNO Financial management to meet virtually with Piper Sandler » 15:46
09/16/21
09/16
15:46
09/16/21
15:46
CNO

CNO Financial

$23.70 /

-0.125 (-0.52%)

Virtual Meetings to be…

Virtual Meetings to be held on September 21-22 hosted by Piper Sandler.

ShowHide Related Items >><<
CNO CNO Financial
$23.70 /

-0.125 (-0.52%)

CNO CNO Financial
$23.70 /

-0.125 (-0.52%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
CNO CNO Financial
$23.70 /

-0.125 (-0.52%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:55
09/10/21
09/10
09:55
09/10/21
09:55
HBM

Hudbay Minerals

$6.35 /

+0.46 (+7.81%)

, ALLE

Allegion

$146.76 /

+3.45 (+2.41%)

, RXN

Rexnord

$64.02 /

+1.15 (+1.83%)

, CNO

CNO Financial

$23.91 /

+0.645 (+2.77%)

, EDIT

Editas Medicine

$66.60 /

+2.01 (+3.11%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hudbay Minerals (HBM) upgraded to Outperform from Sector Perform at National Bank with analyst Shane Nagle saying the shares have declined 17% year-to-data on heightened political risks in Peru, but political risks will subside. 2. Allegion (ALLE) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Allegion is a late cycle, non-residential manufacturer that is exposed to the "favorable thematic backdrop" of education stimulus. 3. Rexnord (RXN) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Rexnord is a "high quality, water-levered story" with favorable non-residential exposure. 4. CNO Financial (CNO) upgraded to Overweight from Neutral at Piper Sandler with analyst John Barnidge thinking CNO will outperform the broader life insurance group over the next several quarters. 5. Editas Medicine (EDIT) upgraded to Outperform from Perform at Oppenheimer with analyst Jay Olson saying that he looks forward to EDIT-101 clinical results in LCA10, including safety data and preliminary efficacy endpoints, from low-dose and mid-dose cohorts at RD2021 this month, representing the first clinical data reported by Editas, and believes the cell medicine franchise and in vivo programs beyond ophthalmology offer upside in the longer term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

09/10/21 National Bank
Hudbay Minerals upgraded to Outperform from Sector Perform at National Bank
08/25/21 Credit Suisse
Hudbay Minerals price target lowered to C$11.50 from C$13 at Credit Suisse
07/19/21 Credit Suisse
Hudbay Minerals price target lowered to C$13 from C$14 at Credit Suisse
07/16/21 National Bank
Hudbay Minerals price target raised to C$14 from C$13 at National Bank
ALLE Allegion
$146.76 /

+3.45 (+2.41%)

09/10/21 Goldman Sachs
Allegion upgraded to Buy from Neutral at Goldman Sachs
07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

09/10/21 Goldman Sachs
Rexnord upgraded to Buy from Neutral at Goldman Sachs
09/08/21 KeyBanc
Rexnord price target raised to $72 from $60 at KeyBanc
09/08/21 KeyBanc
Regal Beloit price target raised to $185 from $175 at KeyBanc
08/06/21 Baird
Rexnord price target raised to $70 from $66 at Baird
CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

  • 21
    Jan
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

Upgrade
CNO Financial upgraded to Overweight from Neutral at Piper Sandler » 06:02
09/10/21
09/10
06:02
09/10/21
06:02
CNO

CNO Financial

$23.25 /

+0.015 (+0.06%)

Piper Sandler analyst…

Piper Sandler analyst John Barnidge upgraded CNO Financial Group to Overweight from Neutral with a price target of $27, up from $25. The analyst thinks CNO will outperform the broader life insurance group over the next several quarters. The rise of the delta variant is likely to drive a greater than anticipated level of claims tailwinds for the next couple quarters at least, Barnidge tells investors in a research note. And with the financial markets continuing to be favorable, CNO should continue to experience elevated levels of net investment income, says the analyst.

ShowHide Related Items >><<
CNO CNO Financial
$23.25 /

+0.015 (+0.06%)

CNO CNO Financial
$23.25 /

+0.015 (+0.06%)

07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
03/09/21 B. Riley
CNO Financial price target raised to $30 from $27 at B. Riley Securities
CNO CNO Financial
$23.25 /

+0.015 (+0.06%)

Over a quarter ago
Earnings
CNO Financial reports Q2 operating EPS 66c, consensus 54c » 16:24
07/28/21
07/28
16:24
07/28/21
16:24
CNO

CNO Financial

$22.86 /

+0.045 (+0.20%)

"CNO generated…

"CNO generated strong second quarter results across our businesses, showcasing again the power of our diversified model and the successful execution of our strategic priorities," said Gary Bhojwani, CEO. "Total new annualized premiums increased 35% over the same period in 2020 and are up 10% relative to 2019 levels. Our earnings continued to benefit from the deferral of care in our health lines and solid alternative investment results." "We enter the second half of the year conservatively positioned," added Bhojwani. "While we cannot predict the quarter-to-quarter impacts of the pandemic, we remain focused on maintaining our growth momentum and managing the business to optimize shareholder value over the long term."

ShowHide Related Items >><<
CNO CNO Financial
$22.86 /

+0.045 (+0.20%)

CNO CNO Financial
$22.86 /

+0.045 (+0.20%)

07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
03/09/21 B. Riley
CNO Financial price target raised to $30 from $27 at B. Riley Securities
CNO CNO Financial
$22.86 /

+0.045 (+0.20%)

Recommendations
CNO Financial price target lowered to $25 from $28 at Piper Sandler » 06:12
07/08/21
07/08
06:12
07/08/21
06:12
CNO

CNO Financial

$23.52 /

+0.17 (+0.73%)

Piper Sandler analyst…

Piper Sandler analyst John Barnidge lowered the firm's price target on CNO Financial to $25 from $28 and keeps a Neutral rating on the shares. Life insurance valuations are higher than just a quarter prior, which suggest this is a "stock pickers' focused market for outperformance prospectively as opposed to a broad macro trade." The analyst believes Aflac (AFL), MetLife (MET) and Reinsurance Group of America (RGA) are the names to own into earnings.

ShowHide Related Items >><<
CNO CNO Financial
$23.52 /

+0.17 (+0.73%)

CNO CNO Financial
$23.52 /

+0.17 (+0.73%)

03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
03/09/21 B. Riley
CNO Financial price target raised to $30 from $27 at B. Riley Securities
01/07/21 B. Riley
CNO Financial price target raised to $27 from $24 at B. Riley Securities
CNO CNO Financial
$23.52 /

+0.17 (+0.73%)

Conference/Events
CNO Financial management to meet virtually with B. Riley Securities » 04:55
05/26/21
05/26
04:55
05/26/21
04:55
CNO

CNO Financial

$26.14 /

-0.765 (-2.84%)

Virtual Meeting to be…

Virtual Meeting to be held on May 26 hosted by B. Riley Securities.

ShowHide Related Items >><<
CNO CNO Financial
$26.14 /

-0.765 (-2.84%)

CNO CNO Financial
$26.14 /

-0.765 (-2.84%)

03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
03/09/21 B. Riley
CNO Financial price target raised to $30 from $27 at B. Riley Securities
01/07/21 B. Riley
CNO Financial price target raised to $27 from $24 at B. Riley Securities
CNO CNO Financial
$26.14 /

-0.765 (-2.84%)

Conference/Events
CNO Financial management to meet virtually with B. Riley Securities » 15:46
05/21/21
05/21
15:46
05/21/21
15:46
CNO

CNO Financial

$27.05 /

+0.21 (+0.78%)

Virtual Meeting to be…

Virtual Meeting to be held on May 26 hosted by B. Riley Securities.

ShowHide Related Items >><<
CNO CNO Financial
$27.05 /

+0.21 (+0.78%)

CNO CNO Financial
$27.05 /

+0.21 (+0.78%)

03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
03/09/21 B. Riley
CNO Financial price target raised to $30 from $27 at B. Riley Securities
01/07/21 B. Riley
CNO Financial price target raised to $27 from $24 at B. Riley Securities
CNO CNO Financial
$27.05 /

+0.21 (+0.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.